View all IQVIA events
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
NHS Solutions
-
Life Sciences Industry
-
Advancing UK Healthcare
-
Pharmacy Communications
NHS Solutions
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreNHS Solutions
Life Sciences Industry
We believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreLife Sciences Industry Solutions
Advancing UK Healthcare
We are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn MoreAdvancing UK Healthcare Solutions
Pharmacy Communications
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreBLOGS, WHITEPAPERS & CASE STUDIES
Explore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn MoreA review of the prescription medicines market in the EU4, UK, US, and Japan through Q3 2022, and a deep dive primary research study into the ongoing impact of the pandemic on patient care in cancer
In this webinar, IQVIA experts cover two key topics. First, we take stock of recent prescription (Rx) medicine market trends to Q3 of 2022 with a view on 2023. In this section, we will:- Examine the current status of global COVID-19 vaccination and treatments as we enter the winter season
- Assess long term and recent post Pandemic trends in Rx markets of key countries: US, Japan, UK, Germany, France, Italy, Spain, with a focus on key therapeutic markets
- Share the latest updates on innovative launch performance across these countries
Next, we’ll share the results of our latest primary research in Oncology, now the world’s most important Rx medicine market. With severe disruption to cancer patients’ care due to the Pandemic, our experts also reveal the latest results of our ongoing primary research series with oncologists and haematologists across the EU4, UK and US. We explore how their workload and their engagement with patients continues to evolve, and how cancer patient care, in all its aspects, has changed. Finally, we’ll discuss the unmet needs in patient care and doctors’ perception of how pharmaceutical companies can support.